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The aim of the present study was to investigate the anti-schistosomal activity of colostral and mature camel 
milk on Schistosoma mansoni infected mice. Six weeks post infection, mean percentage of protection was
detected through the hepatic portal vein. Glutathione-s-transferase (GST), alanine, aspartate transamiase (ALT 
and AST) and immunoglobulin G (IgG) levels were detected in sera of treated mice before and after infection.  
Antischistosomal activity of colostral and mature camel milk on Schistosoma mansoni infected mice were 
12.81% and 31.60% respectively.  The results showed that GST levels in sera of mice fed on colostral and 
mature camel milk were increased with mean values of 0.070, 0.108, 0.128 and 0.120 in colostral milk groups 
and 0. 072, 0.085, 0.166 and 0.20 in mature camel milk groups compared with the mice fed on basal dietwith 
means values of 0.070, 0.085, 0.078 and 0.069 before infection and after two, four and six weeks of infection, 
respectively.  On the other hand, there were slight differences on ALT and AST activities.  Mice treatd with 
colostral and mature milk (200 µl/day) showed an immunostimulatory effect by inducing IgG titers against 
soluble worm antigen preparation (SWAP) compared with control.  Nevertheless, the difference was not 
considered significant (0.31 ± 0.1) for colostrum (0.34 ± 0.1) and for mature milk, as compared to normal 
control (0.2 ± 0.04).  Two, four and six weeks post infection, IgG level showed no significant change in sera 
from mice treated with colostral and mature milk as compared to control. In conclusion, colostral and mature 
camel milk showed an immunomodualatory effect in normal healthy mice by inducing IgG and GST levels 
before and after infection with Schistosoma mansoni. Colostral and mature camel milk have a protective 
response against schistosomiasis. 
 





Camel milk is given to the sick, the elderly and the very 
young because of the belief that it is not only healt ier, but 
it works especially well in bone formation. The belief 
among the Bedouin of the Sinai Peninsula is that drinking 
camel milk can cure any internal disease.1   Camel colo-
strum has total solids of 50.4%. Postpartum solids de-
crease to 18.4 %  after the two days of lactation. This de-
cline was due to the decrease in protein and minerals rather 
than its fat content.2   Compared to cow, buffalo and ewe 
milk fat, camel milk fat contained less short-chained fatty 
acids, but the same long-chained fatty acids can be found. 
Compared with cow's milk, colostral and mature camel 
milk contain a high quantity of protective milk proteins, 
especially lactoferrin, which has multifunction proerties 
in clinical nutrition.3 
     Schistosomiasis is one of the most wide spread parasitic 
infections of man, next to malaria. The major infectious 
species for human are Schistosoma mansoni, Schistosoma 
haematobium and Schistosoma japonicum. Five to fifteen 
percent of subjects infected by Schistosoma mansoni 
develop a severe hepatosplenic disease that may be fatal if 
left untreated.4 Although infections can be cured by 
schistosomicides, chemotherapy is not appropriate for the 
long-term control of these infections and a major World 
Health Organisation objecttive is the develop-ment of a 
vaccine against schistosomiasis. 5 
     The host is exposed to antigens produced by several sta-
ges of the parasite and its products, all of which elicit a 
very intense humoral response.  In terms of antibodies, 
IgGl, IgG2, IgG3, IgG4, IgA, IgE and IgM have all been 
shown to be stimulated by schistsome infection.6  Immu-
nomodulators of natural origin can modulate the immune 
response by  utilizing the host's endogenous substances or 
by using exogenous products of various sources.  Immuno-
modulators include any agent or substance that has a sti-
mulatory, suppressive or regulatory effect. However, the 
differentiation between immunoregulators and immuno-
stimulants is not always clearly defined.7 
     Colostral and camel milk contain a very high quantity of 
protective and bioactive proteins that play an important role 
in the immune system response and in protecting  the body  
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   against infections.  Besides the stimulation of the immune   
system,   scientific  studies   have   revealed  that lacto-
ferrin also prevents the growth of pathogens, exerts anti-
bacterial and antiviral properties, controls cell and tissue 
damage caused by oxidation, and facilitates iron tra sport.  
In addition, these bioactive proteins contribute to the pri-
mary defense system against invading pathogenic orga-
nisms, they stimulate the immune system and the growth 
of various cell lines, help regulate iron status in the body 
and also serve as natural antioxidants.3 
     The aim of the present study is to determine wh ther 
camel milk modulates the immune responses of Schisto-
soma mansoni infected mice.  This study was conducted in 
accordance with the internationally agreed ethical prin-
ciples for the conduct of medical research. 
 
Materials and methods 
Colostral and mature camel milk 
Camel milk and colostrum were obtained from a camel 
local farm (Egyptian Hegin Co.). 
 
Diets and animals  
The composition of basal diets used in this study are milk 
protein (12%), sucrose (5%), fat (10%), vitamin mixtures 
(1%), salt mixtures (4%), fiber (4%) and starch (64%). 
Thirty female Swiss albino mice (18-20 gram) were divi-
ded randomly into three-test groups (each containing 10 
mice). Animals were placed in cages and were given th  
diets containing colostral and mature camel milk for 45 
days. The first group (G1) was fed on the basal diet + 
Colostral camel milk injected orally (200lµ/mouse/day). 
The second group (G2) was fed on basal diet + mature 
camel milk injected orally (200µl/mouse/day). The tird 
group (G3) was fed on basal diet only. 
 
Infection and experimental groups 
After forty-five days post feeding, each mouse was 
infected subcutaneously (S.C.) with 100 Schistosoma 
mansoni cercariae.  
 
Assessment of worms burden  
Perfusion and recovery of adult worms were performed at 
6 weeks post infection through hepatic portal vein by the 
perfusion method.8  The total number of worms in the 
liver and intestine were determined. Protection was 
assessed as the percentage reduction in worm counts in 





Where, P: percentage reduction of worms.  
C: mean worm burdens in control infected animals. 
T: mean worm burdens in pre-treated infected animals 
 
Preparation of sera from feeding mice before and after 
infection with Schistosoma mansoni 
After forty-five days post feeding the blood was collected 
from colostral, mature as well as basal diet feeding mice. 
Six weeks post-infection, the blood was allowed to coa-
gulate at room temperature for 15 min. Sera were obtained 
by centrifugation at 3000 r.p.m and kept in aliquots a  -
80ºC until used. 
 
Detection of IgG levels against soluble worm antigen 
preparation (SWAP) using enzyme-linked immuno-
assay (ELISA)  
Enzyme linked immunosorbent assay was performed 
according to Hiller et al.9  Plates were coated with cer-
carial soluble worm and soluble egg antigens SWAP.  The 
antigens were diluted to 10 µg/ml in 50mM carbonate 
buffer, pH 9.6 (100 µL/well) and incubated overnight at 
4°C.  Plates were washed with the working buffer (PBS-
T20) and blocked for sites free of antigen against non-
specific binding using 200 µL/well of 1% Bovine serum 
albumin in the blocking buffer (PBS-T20-BSA), for one 
hour at room temperature.  Sera from S. mansoni infected 
control and treated infected mice were used at dilution 
1:100 in PBS (100 µL/well) and the plates were incubated 
at room temperature for 2 hrs then washed three tims 
using working buffer (PBS-T20). 100µl of anti-mouse IgG 
and IgM peroxidase conjugate were used at dilution of 
1:3000 and 1:10000 in PBS-T20-BSA respectively for one
hour at room temperature. Bound antibody was detected 
by the addition of O-phenylene diamine dihydrochloride 
(OPD) as a substrate for visualization of the enzymatic 
reaction.  The reaction was developed for 30 min. at room 
temperature and stopped using 50 µL/well of 4 M H2SO4. 
The change in optical densities was recorded at λ max 490 
nm by the aid of an automatic Titertek multiskan Reader 
model ELX 800 UV, INC, USA for reading ELISA plated.  
 
Determination of GST 
The enzyme activity of GST was determined according to 
Habig et al.10   Method is based on the fact that the GST 
enzyme catalyzes the conjugation of glutathione with 1-
chlor 2,4 dinitrobenzene (CDNB) and forms a complex 
which has an absorbance at UV region (340 nm). The 
mean decrease of absorbance per min was calculated. To 
100µl serum, 100µl glutathione solution, 10 µl fresh 
CDNB and 1290µl phosphate buffer were added and 
gently mixed.  The contents were incubated at room te -
perature for 1hour.  The U.V absorbance was measured 
using UV spectrophotometer at 340nm.  The UV absor-
bance of blank was obtained using assay mixture without 
serum.  Enzyme activity was defined as the amount of 
enzyme catalyzing the formation of  1mol of  products per 
min under condition of assay. 
Activity = A 340 nm/(9.6) x 1000 = M/min. 
 
Determination of alanine and aspartate transaminase  
(ALT& AST) activities  
Alanine and aspartate transaminase (ALT& AST) acti-
vities were determined according to the method described 
by Reitman and Frankel.11 
 
Statistical analysis  
Mean and standard error of the obtained data from each 
different experimental group were calculated. One-way 
Analysis of Variance (ANOVA) was applied to the data 
versus the corresponding values of the control.  Differen-
ces were higher than the theoretical one at P ≤ 0.05. 
Statistical analysis of variance (t-test) of glutathione s- 
transferase, alanine and aspartate transaminase (ALT& 
AST) activities within groups and between groups was 
conducted as described by Miller and Miller.12 
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Results 
Anti-schistosomal activity of colostral and mature camel 
milk  
Figure 1 and 2 showed that the level of protection against 
schistosomiasis with 12.8% and 31.6% reduction in total 
worm burden in Colostral Camel milk (G1 ) and mature 
camel milk (G2), respectively as compared to  positive 
control  (Control) infected.  
 
Glutathione S- transferase (GST) and transaminases 
liver enzymes (ALT and AST) activities in sera 
Table (1) shows the glutathione S-transferase (GST) levels 
in mice fed on the experimental diets.  GST levels in m ce 
fed on colostral and mature camel milk were the highest 
compared with mice fed on basal diet. The results showed 
that glutathione S-transferase (GST) levels in mice fed on 
colostral and mature camel milk were increased with 
means values of 0.070, 0.108, 0.128 and 0.120 in colostral 
milk groups and 0.072, 0.085, 0.166 and 0.20 in mature 
camel milk groups compared with the mice fed on basal 
diet with means values of 0.070, 0.085, 0.078 and 0.069 
before infection and after two, four and six weeks of 
infection with Cercariae of Schistosoma mansoni re-
spectively  (Table 1). 
 
Detection of IgG level in sera from mice treated with 
colostral and mature milk of camel before and after 
infection with Schistosoma mansoni 
One-way analysis of variance (ANOVA) showed posi- 
tive reactivity for IgG levels in sera from mice treated 
with colostral (0.32 ± 0.08) and mature milk (0.35 ± 0.08),  
forty five days post feeding, in comparison to sera from 
untreated mice (0.22 ± 0.03) (Fig.3). Post infection with 
S.mansoni cercariae, sera from colostral (0.28± 0.05, 
0.27± 0.04 and 0.32± 0.09) and mature milk (0.12± 0.01, 





























































































 Min Max Mean S.D. A/9.6*1000 
Basal diet befor infection 0.0678 0.0721 0.0702 0.0022 7.316 
Colostral camel milk before infection 0.070 0.0702 0.0702 0.0001 7.302 
Camel milk before infection 0.071 0.072 0.0725 0.0007 7.444 
Basal diet after two weeks of infection 0.0778 0.0986 0.0851 0.0117 8.861 
Colostral camel milk after two weeks of 
infection 
0.1085 0.1097 0.1089 0.0007 11.344 
Camel milk after  two weeks of infection 0.080 0.091 0.0855 0.0078 8.906 
Basal diet after four weeks of infection 0.0738 0.0837 0.0787 0.00625 8.301 
Colostral camel milk after four weeks of 
infection 
0.1260 0.1338 0.1282 0.0049 13.351 
Camel milk after four weeks of infection 0.133 0.20 0.1665 0.0474 17.344 
Basal diet after six weeks of infection 0.0688 0.070 0.0691 0.0008 7.201 
Colostral camel milk after six weeks of 
infection 
0.120 0.121 0.120 0.0007 12.490 
Camel milk after six weeks of infection 0.199 0.21 0.200 0.0007 20.781 
   Min: Minimum concentration;  Max: Maximum concentration ; SD: Standard Divination;  C.V.: Coefficient of Variation 
 
 
  Table 1. Glutathione S-transferase levels in sera of mice fed on colostral and mature camel milk  
 
Figure 1.  Mean number of worm burden in PBS and colostral 
camel (A and B column respectively) milk after 6 weeks post 
infection with Schistosoma mansoni infection. 
 
Figure 2.  Mean number of worm burden in PBS and mature camel 
milk (A and B column respectively) after 6 weeks post infection with 


































Figure 3. Detection of IgG level in sera from mice injected 




Figure 4. Detection of IgG level in sera from mice injected  
orally by PBS, colostral and mature camel milk (A, B, C  
column) respectively at 2 weeks post infection with  































Figure 5. Detection of IgG level in sera from mice  
injected orally by colostral and mature camel milk (A, B,  
C column) respectively at 4 weeks post infection with  
Schistosoma mansoni cercariae. 
 
 
Figure 6. Detection of IgG reactivity in sera of mice fed  
on mature and colostral milk of camel and infected six weeks  
with Schistosoma manson (A, B & C column). 
 
 
sAST (U/L) sALT (U/L) 
Experimental groups 
Min Max Mean S.D. Min Max Mean S.D. 
Basal diet  
before infection 
25.1 29.50 26.07 2.506 16.90 20.22 18.40 1.68 
Colostral camel milk  
before infection 
26.10 28.22 27.10 1.064 16.1 18.21 17.15 1.490 
Camel milk  
before infection 
23.90 28.90 26.41 3.521 17.90 17.92 17.91 0.0071 
Basal diet after  
two weeks of infection 
24.10 27.20 26.06 1.704 16.89 19.88 18.22 1.521 
Colostral camel after  
two weeks of infection 
24.50 25.90 25.37 0.761 17.00 18.29 17.79 0.696 
Camel milk after  
two weeks of infection 
25.70 25.90 25.81 0.127 16.11 18.22 17.17 1.492 
Basal diet after  
four weeks of infection 
24.50 25.90 26.32 2.931 18.72 20 19.36 1.501 
Colostral camel after  
four weeks of infection 
23.92 28.90 25.77 2.723 16.50 17.91 17.43 0.8112 
Camel milk after  
four  weeks of infection 
25.70 25.90 25.81 0.127 18.10 18.30 18.19 0.1334 
Basal diet after  
six weeks of infection 
28.10 29.22 28.66 4.176 17.50 18.21 17.93 0.382 
Colostral camel milk after  
six weeks of infection 
19.32 28.99 24.93 5.021 17.11 17.22 17.44 0.485 
Camel milk after  
six weeks of infection 
24.10 26.90 25.49 1.965 18.10 19.90 19.01 1.258 
 Min: Minimum concentration; Max: Maximum concentration; SD: Standard Divination;  .V.: Coefficient ofVariation 
Table 2. ALT and AST (U/ml) levels in mice fed on colostral and mature camel milk  
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no significant change in IgG levels at regular time inter-
als 2, 4, and 6 weeks respectively when compared with 
that in sera of infected untreated groups (0.25 ± 0.01, 0.44  
0.08 and 0.30 ± 0.1) respectively (Fig.4-6). 
 
Discussion 
Our results showed that anti-schistosomal activity of co-
lostral and mature camel milk on Schistosoma mansoni 
infected mice were 12.8 % and 31.60 % respectively.  Rey 
et al.,13  used milk with oltipraz in the urinary schisto-
somiasis patients.  They were treated with a single dose of 
35mg/kg oltipraz, which was given under surveillance to-
gether with either whole milk or herrings in oil. The 
tolerance of the product was very good as only 3% of the 
patients reported vomiting and 3% paresthesias of the 
fingers.  Sixty-six percent of the patients examined on day 
30 and/or on day 90 were egg-negative and egg excretion 
was reduced by at least 90% in 22 other subjects, bringing 
the percentage of good results to 74%.  On day 90, the 
mean egg excretion was reduced by 82.5% in the overall 
population and by 80.9% in the 5 to 14 year-olds. 
     Our data are in agreement with data from a large 
number of epidemiological studies which have assessed 
the influence of milk intake on infectious diseases.13  
Studies have shown that milk proteins such as casein, 
whey proteins and membrane structures, might all exert a 
stimulatory effect on the immune system and a preventi  
effect on many diseases such as cancer and infectious 
diseases.  Also, whey proteins were found to be protective 
relative to other protein sources,14  this being associated 
with an increase in the intracellular levels of glutathione 
(GSH), where whey is a prime source of precursors.  
When liver glutathione levels rise, the liver is able to more 
effectively detoxify the body also; undenatured whey 
protein optimizes serum and liver glutathione levels.15 
      So, there is a relationship between Schistosome GST 
and immune response.  Whereas, GST is one from multi-
epitope Schistosome vaccine candidates tested for protec-
tive immunogenicity in mice. Several promising can-
didate vaccine antigens including the glycolytic enzymes 
triose-phosphate isomerase (Sm TPI), a 28 kDa gluta-
thione-S-transferase (Sm 28), the myofibrilar protein para-
myosine (Sm 97), an integral membrane protein (Sm 23) 
and Calpain (Sm calpain) have been characterized by their 
primary sequences derived for Schistosoma mansoni.16 
       In numerous animal models, vaccination with GST of 
28 kDa has been shown to generate an immune response 
strongly limiting the worm fecundity, in addition to he re-
duction of the parasite burden.17   Mice and baboons were 
injected with two of Sm 28 GST in the presence of alu-
minum hydroxide and Bordetella pertussis. This reduc 
female Schistosome fecundity by 33% with more pro-
nounced effects (66%) on faecal egg output and a decrease 
of the mean granuloma surface in the liver after experi-
mental infection with Schistosoma mansoni.18 
     Immunization of mice with Sm 28 GST/liposome com-
plex followed by challenge with Schistosoma mansoni 
showed that 28 GST given orally bore protective activity. 
This result opens the possibility of mucosal vaccinatio  
against Schistosomes.19  Costa et al., 20 showed that egg-
hatching inhibition in mice immunized with recombinant  
Schistosome bovis 28 kD GST.  Mice immunized with 14-
3-3GST led to protection ranging from 25-46% as deter-
mined by reduction of adult worm burden after challen-
ging with Schistosoma mansoni.21 
     The cellular and humoral acquired immune respon es 
to Schistosoma haemtobium 28 GST (Sh28 GST) antigen 
were evaluated in a Senegalese population chronically 
i fected with Schistosoma haemtobium parasite.22   Intra-
dermal injection of Sm 28 GST showed a significant re-
duced parasitemia and a decreased egg-induced inflamma-
tory response in the liver and intestine.23    Rezende et al.,24 
showed that GM-CSF and TNF-alfa synergize to increase 
in vitro granuloma size of peripheral blood induced by 
mononuclear cells (PBMC) from human intestinal Schi-
stosomiasis recombinant 28-kDa GST. There is a per-
sistence of the protective immunity (30%) to Schistosoma 
japonicum in yellow cattle induced be recombinant 26 
kDa GST ( resjc 26 GST).25      
     There was a slightly insignificant difference on trans-
aminases liver enzymes (ALT and AST) activities (Table 
2). The activities of aspartate transferase (AST) and la-
nine transferase (ALT) are considerably increased follow-
ing the administration of various hepatotoxic compounds 
that lead to acute hepatocellular damage and/or extra-
hepatic obstructions.26 Therefore, feeding with colostral 
and mature milk of camel stimulates a specific immune re-
sponse that protects against Schistosoma mansoni in-
fection. The immuno-protective response results in an  in-
creased level of GST which is able to more effectively 
detoxify the body. 
     In our study we detected anti-SWAP IgG in sera from 
mice treated with colostral and mature milk before and 
after infection with Schistosoma mansoni. Our results 
showed that colostral and mature milk have immuno-
stimulatory effects by increasing the levels of IgG in mice 
fed with two types of milk.  After infection with S. 
mansoni (2, 4, and 6 weeks) the levels of IgG in sera from 
mice treated with colostral or mature milks showed no sig-
nificant change as compared with untreated infected mice.  
     The data indicated that colostral and mature milk of 
camel play a role in enhancing the immune system and 
increasing resistant factors against Schistosoma mansoni. 
Also, our results are in agreement with Nassr et al.,27 who 
showed that anti-SWAP IgG1 and IgG4 are useful in 
diagnosis and cure. Anti-SWAP IgG1 and IgG4 can be 
used as parameters for evaluating cure.  Follow-up of anti-
schistosomal IgG1 and IgG4 is useful for assess-ment of 
treatment.  In addition, Feng et al.,28 showed that no ob-
vious changes were found in the AWA-IgG4  positive 
rates of 27 schistosomiasis cases before and after treat-
ment, whereas the antibody level of specific IgG4 was 
decreased. Nessim and Demerdash29 showed that prazi-
quantel achieved better cure rates in mice with heavy 
infection (infected with 120 Schistosoma mansoni cer-
cariae) than in less intensely infected animals (infected 
with 60 Schistosoma mansoni cercariae). Finally, colostral 
and mature milk of camel have an immuno-protective re-
sponse against Schistosoma mansoni.  This study sugge -
ted that camel milk can be used with antischistomal drugs 
in Schistosomiasis patients.  
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骆驼初乳和成熟乳对感染曼氏血吸虫的鼠具有抗血吸虫的能力 
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血吸虫的能力分别为 12.81％和 31.60％。结果表明，在感染前和感染后 2、4及 6 个星期，对于鼠血清中 GST
的平均增加值，初乳组、成熟乳组和基础饮食组分别为 0.070、0.108、0.128、0.120，0.072、0.085、
0.166、0.20，0.070、0.085、0.078、0.069。此外，ALT 和 AST 的活性有轻微但不显著的变化。和正常健康
鼠相比，饲喂初乳和成熟乳(200 µl/day)具有免疫刺激作用，可诱导抗可溶性虫抗原制剂的 IgG 效价。然而，
与正常控制组(0.2±0.04)相比，初乳组(0.31±0.1)和成熟乳组(0.34±0.1)的差别不显著。与控制组相比，
在感染 2、4、6星期后，初乳组和成熟乳组血清 IgG 的水平没有显著变化。总之，通过在曼氏血吸虫感染前后
诱导 IgG 和 GST 的水平，骆驼初乳和成熟乳在正常健康鼠中具有免疫调节作用。骆驼初乳和成熟乳具有抗血吸
虫病的作用。 
 
关键词：初乳， 骆驼乳，寄生虫，曼氏血吸虫，血吸虫病，乳铁传递蛋白，谷胱甘肽-s-转移酶，丙氨酸转氨
酶，天冬酰胺转氨酶 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
